Area: ~29 acres, 10 buildings (A1-A10); Buildings 1, 2, 5, 6, 7 are completed and in use; 3 and 4 are being renovated; 8-10 are under construction (as of July 2022).
Capacity: total 424.5kL, including 9x500L, 12x5kL, 24x15kL BRX; fully on-line by end of 2023.
Products: Antibody (majority), CGT, and mRNA.
GMP facilities designed to meet the standards of ICH, FDA, EMA and NMPA
